 |
市場調查報告書
商品編碼
1402202
全球先進治療藥物市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測Global Advanced Therapy Medicinal Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
全球先進治療藥物市場需求預計將從 2022 年的 285.6 億美元達到 2030 年近 1,022.9 億美元的市場規模，2023-2030 年研究期間CAGR為 17.29%。
先進治療藥品 (ATMP) 是一類創新療法，涵蓋一系列用於在細胞或基因層面治療疾病和損傷的尖端醫療產品。這些療法透過利用基因、細胞或組織來針對特定疾病或病症，提供了新的醫療方法。
市場動態
先進治療藥品 (ATMP) 市場正在幾個關鍵因素的推動下實現成長。首先，這些療法解決以前無法治療或管理不善的疾病，滿足癌症、遺傳性疾病和退化性疾病等未滿足的醫療需求。生物技術、基因編輯和組織工程的技術進步極大地促進了 ATMP 的開發和商業化。改進的技術提高了這些療法的功效和安全性，促進了它們的採用和市場擴張。支持性監管框架和快速核准途徑鼓勵對 ATMP 的研究和投資。此外，研發投資的增加，加上製藥公司、生技公司和學術機構之間的合作，推動了該領域的創新。全球慢性病盛行率不斷上升，加上個人化醫療的轉變，進一步擴大了對 ATMP 提供的標靶和個人化治療的需求。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球先進治療藥品市場的每個細分市場進行了包容性評估。先進治療藥品產業的成長和趨勢為本研究提供了整體方法。
區域分析
本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲先進治療藥物產品市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。先進治療藥物產品市場的主要參與者包括 Spark Therapeutics Inc.、Bluebird Bio Inc.、Novartis AG、UniQure NV、Celgene Corporation、Gilead Lifesciences Inc.、Kolon TissueGene Inc.、JCR Pharmaceuticals Co. Ltd.、Medipost、Vericel Corporation 、Pharmicell Co. Ltd、Organogenesis Inc。本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布，以及其他進展。
如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
目錄
第1章：前言
- 報告說明
- 客觀的
- 目標受眾
- 獨特的銷售主張 (USP) 和產品
- 研究範圍
- 研究方法論
- 市場研究過程
- 市場研究方法論
第 2 章：執行摘要
- 市場亮點
- 全球市場概況
第 3 章：先進治療藥品 - 產業分析
- 簡介 - 市場動態
- 市場促進因素
- 市場限制
- 機會
- 產業動態
- 波特五力分析
- 市場吸引力分析
- 按治療類型分類的市場吸引力分析
- 市場吸引力分析：按地區
第 4 章：價值鏈分析
- 價值鏈分析
- 原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
- 潛在買家名單
- 行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢
第 5 章：全球先進治療藥品市場分析：依治療類型
- 按治療類型概述
- 歷史和預測數據
- 依治療類型分析
- 細胞治療（幹細胞治療、非幹細胞治療）
- 基因治療
- 組織工程產品
第 6 章：全球先進治療藥品市場分析：依地理位置
- 區域展望
- 介紹
- 北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
- 歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
- 亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
- 拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
- 中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析
第 7 章：先進治療藥品公司的競爭格局
- 先進治療藥品市場競爭
- 夥伴關係/協作/協議
- 併購
- 新產品發布
- 其他發展
第 8 章：公司簡介
- 公司股份分析
- 市場集中度
- Spark Therapeutics Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Bluebird Bio Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Novartis AG
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- UniQure NV
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Celgene Corporation
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Gilead Lifesciences Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Kolon TissueGene Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- JCR Pharmaceuticals Co. Ltd.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Medipost
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Vericel Corporation
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Pharmicell Co. Ltd
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Organogenesis Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內
The global demand for Advanced Therapy Medicinal Products Market is presumed to reach the market size of nearly USD 102.29 BN by 2030 from USD 28.56 BN in 2022 with a CAGR of 17.29% under the study period 2023 - 2030.
Advanced therapy medicinal products (ATMPs) are a category of innovative therapies that encompass a range of cutting-edge medical products used to treat diseases and injuries at the cellular or genetic level. These therapies offer novel approaches to medical treatment by utilizing genes, cells, or tissues to target specific diseases or conditions.
MARKET DYNAMICS
The Advanced therapy medicinal products (ATMPs) market is experiencing growth driven by several key factors. Firstly, these therapies address previously untreatable or inadequately managed diseases, catering to unmet medical needs in conditions like cancer, genetic disorders, and degenerative diseases. Technological advancements in biotechnology, gene editing, and tissue engineering significantly contribute to the development and commercialization of ATMPs. Improved technologies enhance the efficacy and safety of these therapies, fostering their adoption and market expansion. Supportive regulatory frameworks and expedited approval pathways encourage research and investment in ATMPs. Additionally, increased investments in research and development, coupled with collaborations between pharmaceutical companies, biotech firms, and academic institutions, drive innovation in this field. The rising prevalence of chronic diseases worldwide, coupled with the shift towards personalized medicine, further amplifies the demand for targeted and personalized therapies offered by ATMPs.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of advanced therapy medicinal products. The growth and trends of advanced therapy medicinal products industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the advanced therapy medicinal products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Therapy Type
- Cell Therapy (Stem Cell Therapy, Non-Stem Cell Therapy)
- Gene Therapy
- Tissue Engineered Product
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Advanced Therapy Medicinal Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Advanced Therapy Medicinal Products market include Spark Therapeutics Inc., Bluebird Bio Inc., Novartis AG, UniQure N.V., Celgene Corporation, Gilead Lifesciences Inc., Kolon TissueGene Inc., JCR Pharmaceuticals Co. Ltd., Medipost, Vericel Corporation, Pharmicell Co. Ltd, Organogenesis Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . ADVANCED THERAPY MEDICINAL PRODUCTS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapy Type
- 3.7.2 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET ANALYSIS BY THERAPY TYPE
- 5.1 Overview by Therapy Type
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Therapy Type
- 5.4 Cell Therapy (Stem Cell Therapy, Non-stem Cell Therapy) Historic and Forecast Sales by Regions
- 5.5 Gene Therapy Historic and Forecast Sales by Regions
- 5.6 Tissue Engineered Product Historic and Forecast Sales by Regions
6 . GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET ANALYSIS BY GEOGRAPHY
- 6.1. Regional Outlook
- 6.2. Introduction
- 6.3. North America Sales Analysis
- 6.3.1. Overview, Historic and Forecast Data Sales Analysis
- 6.3.2. North America By Segment Sales Analysis
- 6.3.3. North America By Country Sales Analysis
- 6.3.4. United State Sales Analysis
- 6.3.5. Canada Sales Analysis
- 6.3.6. Mexico Sales Analysis
- 6.4. Europe Sales Analysis
- 6.4.1. Overview, Historic and Forecast Data Sales Analysis
- 6.4.2. Europe by Segment Sales Analysis
- 6.4.3. Europe by Country Sales Analysis
- 6.4.4. United Kingdom Sales Analysis
- 6.4.5. France Sales Analysis
- 6.4.6. Germany Sales Analysis
- 6.4.7. Italy Sales Analysis
- 6.4.8. Russia Sales Analysis
- 6.4.9. Rest Of Europe Sales Analysis
- 6.5. Asia Pacific Sales Analysis
- 6.5.1. Overview, Historic and Forecast Data Sales Analysis
- 6.5.2. Asia Pacific by Segment Sales Analysis
- 6.5.3. Asia Pacific by Country Sales Analysis
- 6.5.4. China Sales Analysis
- 6.5.5. India Sales Analysis
- 6.5.6. Japan Sales Analysis
- 6.5.7. South Korea Sales Analysis
- 6.5.8. Australia Sales Analysis
- 6.5.9. South East Asia Sales Analysis
- 6.5.10. Rest Of Asia Pacific Sales Analysis
- 6.6. Latin America Sales Analysis
- 6.6.1. Overview, Historic and Forecast Data Sales Analysis
- 6.6.2. Latin America by Segment Sales Analysis
- 6.6.3. Latin America by Country Sales Analysis
- 6.6.4. Brazil Sales Analysis
- 6.6.5. Argentina Sales Analysis
- 6.6.6. Peru Sales Analysis
- 6.6.7. Chile Sales Analysis
- 6.6.8. Rest of Latin America Sales Analysis
- 6.7. Middle East & Africa Sales Analysis
- 6.7.1. Overview, Historic and Forecast Data Sales Analysis
- 6.7.2. Middle East & Africa by Segment Sales Analysis
- 6.7.3. Middle East & Africa by Country Sales Analysis
- 6.7.4. Saudi Arabia Sales Analysis
- 6.7.5. UAE Sales Analysis
- 6.7.6. Israel Sales Analysis
- 6.7.7. South Africa Sales Analysis
- 6.7.8. Rest Of Middle East And Africa Sales Analysis
7 . COMPETITIVE LANDSCAPE OF THE ADVANCED THERAPY MEDICINAL PRODUCTS COMPANIES
- 7.1. Advanced Therapy Medicinal Products Market Competition
- 7.2. Partnership/Collaboration/Agreement
- 7.3. Merger And Acquisitions
- 7.4. New Product Launch
- 7.5. Other Developments
8 . COMPANY PROFILES OF ADVANCED THERAPY MEDICINAL PRODUCTS INDUSTRY
- 8.1. Company Share Analysis
- 8.2. Market Concentration Rate
- 8.3. Spark Therapeutics Inc.
- 8.3.1. Company Overview
- 8.3.2. Company Revenue
- 8.3.3. Products
- 8.3.4. Recent Developments
- 8.4. Bluebird Bio Inc.
- 8.4.1. Company Overview
- 8.4.2. Company Revenue
- 8.4.3. Products
- 8.4.4. Recent Developments
- 8.5. Novartis AG
- 8.5.1. Company Overview
- 8.5.2. Company Revenue
- 8.5.3. Products
- 8.5.4. Recent Developments
- 8.6. UniQure N.V.
- 8.6.1. Company Overview
- 8.6.2. Company Revenue
- 8.6.3. Products
- 8.6.4. Recent Developments
- 8.7. Celgene Corporation
- 8.7.1. Company Overview
- 8.7.2. Company Revenue
- 8.7.3. Products
- 8.7.4. Recent Developments
- 8.8. Gilead Lifesciences Inc.
- 8.8.1. Company Overview
- 8.8.2. Company Revenue
- 8.8.3. Products
- 8.8.4. Recent Developments
- 8.9. Kolon TissueGene Inc.
- 8.9.1. Company Overview
- 8.9.2. Company Revenue
- 8.9.3. Products
- 8.9.4. Recent Developments
- 8.10. JCR Pharmaceuticals Co. Ltd.
- 8.10.1. Company Overview
- 8.10.2. Company Revenue
- 8.10.3. Products
- 8.10.4. Recent Developments
- 8.11. Medipost
- 8.11.1. Company Overview
- 8.11.2. Company Revenue
- 8.11.3. Products
- 8.11.4. Recent Developments
- 8.12. Vericel Corporation
- 8.12.1. Company Overview
- 8.12.2. Company Revenue
- 8.12.3. Products
- 8.12.4. Recent Developments
- 8.13. Pharmicell Co. Ltd
- 8.13.1. Company Overview
- 8.13.2. Company Revenue
- 8.13.3. Products
- 8.13.4. Recent Developments
- 8.14. Organogenesis Inc.
- 8.14.1. Company Overview
- 8.14.2. Company Revenue
- 8.14.3. Products
- 8.14.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Therapy Type (USD MN)
- Cell Therapy (Stem Cell Therapy, Non-stem Cell Therapy) Market Sales by Geography (USD MN)
- Gene Therapy Market Sales by Geography (USD MN)
- Tissue Engineered Product Market Sales by Geography (USD MN)
- Global Advanced Therapy Medicinal Products Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Advanced Therapy Medicinal Products Report
- Market Research Process
- Market Research Methodology
- Global Advanced Therapy Medicinal Products Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Therapy Type
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Therapy Type (USD MN)
- Cell Therapy (Stem Cell Therapy, Non-stem Cell Therapy) Market Sales by Geography (USD MN)
- Gene Therapy Market Sales by Geography (USD MN)
- Tissue Engineered Product Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Company Market Share Analysis
